Navigation Links
EXAMINE-Studie zur kardiovaskulären Sicherheit von Alogliptin erreicht primären Endpunkt: keine Erhöhung des kardiovaskulären Risikos bei Risikopatienten mit Typ-2 Diabetes
Date:9/11/2013

sgemäß den Behörden mitgeteilt.

Informationen zu Diabetes Typ 2
Diabetes Typ 2 ist die häufigste Form von Diabetes, unter der Millionen Menschen weltweit leiden. Diabetes Typ 2 ist eine fortschreitende und chronische Erkrankung; Patienten sollten ihre Erkrankung regelmäßig von einem Arzt kontrollieren lassen. Neben Diät und Bewegung müssen die Patienten häufig ein oder mehrere Medikamente einnehmen, um ihren Blutzuckerspiegel unter Kontrolle zu halten. Der „International Diabetes Federation" zufolge beliefen sich die Gesundheitsausgaben für Diabetes (Typ 1 und 2) im Jahr 2012 auf mehr als 471 Milliarden USD. Es wird geschätzt, dass dieser Betrag bis 2030 595 Milliarden USD überschreiten wird.

Informationen zu Alogliptin
Alogliptin ist ein Dipeptidylpeptidase-4-Inhibitor (DPP-4i) zur Behandlung von Diabetes Typ 2 bei Erwachsenen, in Ergänzung zu Diät und Bewegung. DPP-4is verlangsamen die Deaktivierung der Incretin-Hormone GLP-1 und GIP. Durch eine erhöhte Menge an aktiven Inkretinen kann die Bauchspeicheldrüse Insulin Glukose-abhängig sezernieren und so die Kontrolle des Blutzuckerspiegels unterstützen. Das japanische Ministerium für Gesundheit, Arbeit und Wohlfahrt ließ im April 2010 eine New Drug Application (NDA) für NESINA (Alogliptin) zur Behandlung von Diabetes Typ 2 zu; das Medikament ist in Japan unter eben diesem Markennamen erhältlich. NESINA (Alogliptin) wurde von der US-amerikanischen FDA im Januar 2013 sowohl als  Monotherapie als auch als Kombinationstherapie  (fixed-dose combination, FDC) mit Pioglitazon (OSENI) und Metformin (KAZANO) für die Behandlung von Diabetes Typ 2 bei Erwachsenen als Ergänzung zu Diät und Bewegung zugelassen. Alogliptin als Monopräparat ist gegenwärtig in Tablettendosierungen zu 6,25 mg,
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. American College of Chest Physicians (ACCP) und Simbionix arbeiten zusammen, um klinische Ausbildung und Patientensicherheit zu verbessern
2. Messe/Konferenz InnoPack Pharma legt den Fokus auf innovative Verpackungen für Compliance und Sicherheit
3. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
4. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
5. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
8. Clinilabs Sponsors The ADAs 2013 Step Out: Walk to Stop Diabetes
9. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
10. Elcelyx Therapeutics NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
11. Bio-Solutions Corp. Expanding in Booming Diabetes Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015  Johnson & Johnson (NYSE: JNJ ... for the investment community beginning at 8:30 a.m. (Eastern ... Regency Hotel in New Brunswick, New Jersey ... Paul Stoffels , M.D., Worldwide Chairman Pharmaceuticals, ... Worldwide Chairman, Pharmaceuticals will host the meeting. Dominic ...
(Date:4/20/2015)... DUBLIN , Apr. 14, 2015 Research and ... addition of the "US Proton Therapy Outlook - ... According to the US Proton Therapy Outlook: Market Opportunities ... will be home to almost 29 such centers ... current figure. Consequently, the market will breach the Billion ...
(Date:4/20/2015)... 2015  Ameritox,s Ingenuity Health, a leading provider of ... research at the National Council of Behavioral Health annual ... that nearly 25 percent of the samples collected from ... the prescribed antipsychotic medication. ... Medication ...
Breaking Medicine Technology:United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... Dec. 1, 2011 Mylan Inc. (Nasdaq: MYL ) ... Besylate and Atorvastatin Calcium Tablets, 2.5 mg/10 mg, 2.5 mg/20 mg, ... mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 ... Caduet ® Tablets, which are used in the treatment of ...
... 2011  Henry Schein, Inc., (NASDAQ: HSIC ), ... to office-based practitioners, announced today that Stanley Bergman, Chairman ... Paladino, the Company,s Executive Vice President and Chief Financial ... Program on December 6.  The conference is being held ...
Cached Medicine Technology:Henry Schein to Present at the NASDAQ OMX 27th Investor Program 2
(Date:4/20/2015)... Florida Hospital at Connerton Long Term Acute Care ... Medical, during the annual ceremony hosted at the Grand ... Officer, Debi Martoccio, received the Leadership Award for demonstrating ... recipients out of 113 hospitals nationwide. The hospital also ... contributions to the community as well as a separate ...
(Date:4/20/2015)... TROY Healthcare Solutions will be hosting ... software, which provides the ultimate level of security for ... the Anthem Suite Hotel in the Socrates Room, located ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief 15-20 minute presentations each ...
(Date:4/20/2015)... 2015 “ Verus ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... of purposes. , According to CNET, at least a ... 2013. It’s unfortunate that smartphones break so easily, but ...
(Date:4/20/2015)... "It's so hard to put into words ... I really thought I would just be paying for ... I've discovered is this need that other baby loss ... other and walk through this journey together," says Ramsey ... more from these families than I could ever hope ...
(Date:4/20/2015)... Spring Hill, FL (PRWEB) April 20, 2015 ... public health issue in the United States for decades. ... lives, lost productivity, healthcare costs and property damage each ... on its victims, as well as their families and ... Suncoast Rehabilitation Center is dedicated to raising ...
Breaking Medicine News(10 mins):Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 4
... blame, Japanese study finds , , THURSDAY, Dec. 11 (HealthDay News) ... new Japanese study finds. , Those living in multigenerational households ... more likely to be diagnosed with serious heart disease than ... researchers at Osaka University reported in the Dec. 11 online ...
... the age of 90, living well beyond the age of 100 and ... the secret to the fountain of youth. And now, this information is ... ... Wire EON) December 11, 2008 -- Natural Health News Report is ...
... 11 The Susan G. Komen for the Cure(R),Advocacy Alliance ... the next Secretary of Health and Human Services and director ... Alliance noted that,Daschle has long been a leader on health ... years related to breast cancer. , ...
... for Americans to "Tell Their Stories" , ... has indicated that healthcare reform will be a top priority ... offer to serve as health and human services secretary, is ... asking Americans to help with reform efforts by sharing their ...
... Philadelphia, 11 December 2008 Heart failure (HF) clinics ... patients with heart failure, yet there have been no ... clinics. To address this gap, the Quality of ... (HFSA) has developed a consensus statement summarizing the rationale, ...
... aim to strengthen science in selected member states of ... Member States hosting the grantees finance the grants entirely. ... the Czech Republic, Estonia, Hungary, Poland, Portugal and Turkey. ... to five years to help them establish their groups ...
Cached Medicine News:Health News:Crowded Households Raise Women's Heart Risk 2Health News:Crowded Households Raise Women's Heart Risk 3Health News: Anti-Aging Miracle Physicians Have Been Waiting for is Finally Here : Free Book Available From Natural Health News Report Reveals the Secret to Staying Young 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar 2Health News:Hospice Community Encouraged to Respond to Daschle Request to Participate in Information Gathering about Healthcare Concerns 2Health News:New statement outlines essentials of heart failure clinics 2
... The Rotanta 460 family ... extraordinary line that meets ... demands. They feature high ... Their state-of-the-art technology and ...
... 15 centrifuge provides all the ... for today's full-service clinical lab ... a speed up to 15,300 ... spin tubes, plates and rotors ...
... Autocrit Ultra has an uniquely ... a facility in which tubes ... in the same carrying tray. ... built-in magnifier, quiet operation, automatic ...
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This centrifuge is available in a nonrefrigerated model with a speed up ...
Medicine Products: